The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Launched by UNIVERSITAS DIPONEGORO · Sep 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how useful a specific blood test called the anion gap can be in predicting serious heart problems in patients who have had a heart attack known as ST-segment elevation myocardial infarction (STEMI). The researchers will gather data from hospital records of patients who are between 18 and 70 years old, have been diagnosed with STEMI, and have undergone a procedure called primary percutaneous coronary intervention (PPCI) to open blocked blood vessels in the heart. They will look at a variety of information, including patient demographics, clinical details, and lab results.

To participate in this study, individuals must be within the age range mentioned and meet the criteria of having had a STEMI and undergone PPCI. However, those with a history of heart failure, certain infections, pregnant individuals, or other conditions that could affect the anion gap will not be eligible. Participants can expect their medical information to be reviewed and analyzed to help understand if the anion gap can better predict future heart-related events for patients like them. This research aims to improve care for future heart attack patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI
• Exclusion Criteria:
• • History of heart failure due to any causes
• • Cardiogenic shock before PPCI
• • Any infection at the time of presentation
• • Pregnant woman
• • Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc